Stay updated with breaking news from Consumer Operations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Marriott has announced that its CEO Arne Sorenson has passed away. The hotel chain said that Sorenson passed away unexpectedly on Feb. 15, 2021. The announcement comes just two weeks after the hotel chain said that Sorenson would be stepping back from his role in order to undergo more demanding treatment. Sign up to receive …
Marriott CEO to step back from role during cancer treatment Feb 2, 2021 This post contains references to products from one or more of our advertisers. We may receive compensation when you click on links to those products. Terms apply to the offers listed on this page. For an explanation of our Advertising Policy, visit this page. Marriott CEO Arne Sorenson is temporarily reducing his schedule in order to undergo more demanding treatment for cancer. The world’s largest hotel chain announced on Tuesday that Sorenson will step back in his role from full-time oversight of the company for “sev...
Marriott President and CEO Arne Sorenson Temporarily Step Backs from Duties for Cancer Treatment Photo: Sam Aronov/Shutterstock.com Marriott International President and CEO Arne Sorenson will be temporarily reducing his schedule as he undergoes more demanding cancer treatment, the company announced on Tuesday. In May 2019, Sorenson revealed he had been diagnosed with stage 2 pancreatic cancer and was beginning treatment. Sorenson, who will remain Marriott’s president and CEO, is expected to step back from full-time oversight of the company for several months. During this time, he will sta...
Marriott President and CEO Arne Sorenson to Temporarily Reduce Schedule for Cancer Treatment Company Puts in Place Interim Management Structure to Oversee Day-to-Day Operations News provided by Share this article Share this article BETHESDA, Md., Feb. 2, 2021 /PRNewswire/ -- Marriott International, Inc. (NASDAQ: MAR) today announced that president and CEO Arne Sorenson will be temporarily reducing his schedule to facilitate more demanding treatment for pancreatic cancer. In May 2019, the company announced that Mr. Sorenson, 62, had been diagnosed with pancreatic cancer and was beginning trea...